Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity

Inhibiting VEGF improves adult retino/choroido-vascular diseases, but can lead to recurrent intravitreous neovascularization (IVNV), avascular retina (AVA), and retinal detachment in preterm infants with retinopathy of prematurity (ROP). We sought to understand causes of late-onset IVNV and AVA foll...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Investigative ophthalmology & visual science Ročník 54; číslo 3; s. 2020
Hlavní autoři:	McCloskey, Manabu, Wang, Haibo, Jiang, Yanchao, Smith, George Wesley, Strange, Jeremy, Hartnett, M Elizabeth
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 21.03.2013
Témata:	Animals Antibodies - pharmacology Biomarkers - metabolism Blotting, Western Body Weight - drug effects Case-Control Studies Disease Models, Animal Erythropoietin - metabolism Humans Infant, Newborn Neovascularization, Pathologic - chemically induced Rats Rats, Sprague-Dawley Retina - drug effects Retinopathy of Prematurity - drug therapy STAT3 Transcription Factor - metabolism Vascular Endothelial Growth Factor A - pharmacology Vascular Endothelial Growth Factor Receptor-2 - metabolism
ISSN:	1552-5783, 1552-5783
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!